218 related articles for article (PubMed ID: 6173340)
1. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
[TBL] [Abstract][Full Text] [Related]
2. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
3. Experimental studies of new anthracyclines: aclacinomycin, THP-adriamycin and ditrisarubicins.
Umezawa K; Kunimoto S; Takeuchi T
Biomed Pharmacother; 1987; 41(5):206-13. PubMed ID: 2444279
[TBL] [Abstract][Full Text] [Related]
4. [Low molecular weight immunomodulators produced by microorganisms].
Ishizuka M
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2709-14. PubMed ID: 6508323
[TBL] [Abstract][Full Text] [Related]
5. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganisms.
Umezawa H
Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):19-23. PubMed ID: 7056602
[TBL] [Abstract][Full Text] [Related]
6. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
Ando S; Sasada M; Uchino H; Kagawa D; Ueda T; Nakamura T
Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2343-55. PubMed ID: 3471823
[No Abstract] [Full Text] [Related]
7. [Immunomodulation by antitumor antibiotics].
Ishizuka M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):697-700. PubMed ID: 3963840
[TBL] [Abstract][Full Text] [Related]
8. [Effect of aclacinomycin B on DNA polymerase II of tumor cells].
Li ZR; Feng JB; Han R; Yin MB; Xia LJ
Zhongguo Yao Li Xue Bao; 1985 Sep; 6(3):189-92. PubMed ID: 2943125
[No Abstract] [Full Text] [Related]
9. [Studies on the mechanism of drug resistance in tumor cells and a new antitumor antibiotic].
Tanaka N
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2666-73. PubMed ID: 6210060
[TBL] [Abstract][Full Text] [Related]
10. [Effects of aclacinomycin B on biological macromolecular contents and synthesis of L1210 cells].
Li ZR; Feng JB; Liang F; Zeng SX; Han R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Jun; 6(3):174-8. PubMed ID: 6241042
[No Abstract] [Full Text] [Related]
11. [Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines].
Ota K; Goto T; Fukushima M; Ariyoshi Y
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1352-61. PubMed ID: 6191712
[TBL] [Abstract][Full Text] [Related]
12. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
[No Abstract] [Full Text] [Related]
13. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
[TBL] [Abstract][Full Text] [Related]
14. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
Levey BA; Ruiz E; Rogerson B; Lehotay DC; Levey GS
Cancer Treat Rep; 1980; 64(10-11):1127-8. PubMed ID: 6109566
[No Abstract] [Full Text] [Related]
15. Antitumor antibiotics and low molecular weight immunomodifiers of microbial origin.
Umezawa H
Cancer Treat Rep; 1984 Jan; 68(1):137-44. PubMed ID: 6692425
[TBL] [Abstract][Full Text] [Related]
16. Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.
Sikic BI; Siddik ZH; Gram TE
Cancer Treat Rep; 1980; 64(4-5):659-67. PubMed ID: 6159079
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
[TBL] [Abstract][Full Text] [Related]
18. Preparation of 4- and 6-O-methyl-aclacinomycin derivatives and their antitumor activities.
Tanaka H; Yoshioka T; Shimauchi Y; Matsushita Y; Matsuzawa Y; Oki T; Inui T
J Antibiot (Tokyo); 1981 Jul; 34(7):905-8. PubMed ID: 7287594
[No Abstract] [Full Text] [Related]
19. Mutagenicity of aclacinomycin A and daunomycin derivatives.
Umezawa K; Sawamura M; Matsushima T; Sugimura T
Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
[TBL] [Abstract][Full Text] [Related]
20. [Study of new antineoplastic antibiotics based on newly discovered action mechanisms].
Tanaka N
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1094-106. PubMed ID: 6191673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]